Innovative research approaches are therefore urgently needed to achieve long-term progress in prevention and ...

A molecular quality-control system in Anopheles mosquitoes-the species responsible for most of the world's malaria cases-is a ...

Epigenetics are one of life's primary drivers of adaptations. They are why human beings who live at high altitude have more ...

The FDA has ordered BioNTech to immediately halt its Phase I/II trial of malaria vaccine candidate BNT165e, pending changes.

Antimalarial drug resistance is a pressing issue in combating the spread of malaria worldwide. In a new study, researchers ...

BioNTech SE (NASDAQ:BNTX) said on Tuesday, that the U.S. Food and Drug Administration informed of a clinical hold on the ...

BioNTech said in a regulatory filing on Tuesday the U.S. Food and Drug Administration has placed a clinical hold on an early-to-mid stage trial of its malaria vaccine.

The FDA’s clinical hold has prompted a cautious response from investors, reflecting the heightened regulatory scrutiny that BioNTech now faces. The company’s immediate focus will be on resolving the ...

Commissions do not affect our editors' opinions or evaluations. The price-to-earnings ratio, or P/E ratio, helps you compare the price of a company’s stock to the earnings the company generates.

Health authorities are conducting tests in regions of DR Congo affected by a mystery disease that has killed 60 people. https://p.dw.com/p/4rC2q Plasmodium falciparum ...

Researchers grew Plasmodium knowlesi in rhesus macaque red blood cells to study which genes are critical for P. knowlesi survival. Image credit: Sheena Dass Malaria affects about 249 million people ...

“Our research shows that PfSnf2L is essential for P. falciparum to dynamically adjust gene expression,” explains Maria Theresia Watzlowik, lead author of the study. “The unique sequence and functional ...